Global Perspectives: Current and Future State of CAR T

Expert perspectives and strategic insights on new and relevant clinical advances of CAR T in DLBCL, ALL, FL, and MCL, including recently presented abstracts at ASCO and EHA.

June 22 and 24, 2021

FACULTY CO-CHAIR

Marie José Kersten, MD, PhD

Academic Medical Center – University of Amsterdam, The Netherlands

FACULTY CO-CHAIR

Frederick Locke, MD

Moffitt Cancer Center, Tampa, FL, USA

FACULTY MEMBERS

Catherine Thieblemont, MD, PhD
Hôpital Saint-Louis, Paris, France

Julio Delgado, MD, PhD
ICMHO, Hospital Clínic de Barcelona, Barcelona, Spain

Max Topp, MD
University Hospital, Würzburg, Germany

Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Matthew Frigault, MD
Massachusetts General Hospital, Boston, MA, USA

Gareth Morgan, MD, PhD
NYU Langone Medical Center, New York, NY, USA

Julio Chavez, MD
Moffitt Cancer Center, Tampa, FL, USA

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Update on CAR T in DLBCL
  • Update on CAR T in ALL
  • Update on CAR T in FL and MCL
  • BCMA-Targeting Agents in MM
  • Current State and Future Directions in CAR T Manufacturing
  • Next-Generation CARs
  • Advances in “Off-the-Shelf” CAR T-Cell Therapy

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.